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Weighlevel, a mixture of extract of four plants used in traditional Arabic and Islamic medicine as well as in European herbal
medicine, was prepared and assessed for its safety and eﬃcacy in weight loss. Leaves of Alchemilla vulgaris, Olea europaea and
Mentha longifolia L., as well as seeds of Cuminum cyminum, were used. Cultured human ﬁbroblasts treated with Weighlevel did
notexhibit anysignoftoxicity asevidenced by lactatedehydrogenase release. These results were conﬁrmedin experimental studies
on rats where an LD50 of 15.3gkg−1 was observed. Signiﬁcant antioxidant properties were seen at very low concentrations of
Weighlevel (10μgml −1) as measured by the lipid peroxidation method. Progressive and signiﬁcant weight loss was observed in
chickens given this mixture weekly for 4 weeks compared with controls. Furthermore, a 3-fold increase in the thermogenesis was
seen in rat interscapular brown adipose tissue following exposure to diﬀerent concentrations of Weighlevel extract as determined
by measurement of increased oxygen consumption. In addition, a clinical study was carried out among 80 human volunteers with
a body mass index (BMI) of 30.67 ± 2.14kgm−2. All 80 subjects were asked to continue their usual diet but to eat only three
main meals daily and to take one Weighlevel tablet 30min before each meal. Fourteen subjects were excluded for not following
the protocol, and 66 subjects were all evaluated for eﬃcacy and tolerability of Weighlevel monthly for 3 months. Weighlevel was
well tolerated by all subjects, and no side eﬀects were reported. A progressive and signiﬁcant weight loss was seen in these subjects
during the whole study period. Higher levels of weight loss were seen in people with BMI of 25–30kgm−2 (overweight) compared
to people with BMI >30kgm−2 (obese). The BMI was reduced after 3 months from 28.5 ± 1.2 and 32.1 ± 1.8kgm−2 to 24.5 ± 1.4
and 27.5 ± 2.2kgm−2 in overweight and obese group, respectively. Results indicate safety, tolerability and eﬃcacy of Weighlevel.
1.Introduction
Overweight is a major health challenge in the Western
world with serious clinical complications such as type 2 dia-
betes mellitus, cerebrovascular and ischemic heart diseases.
Available pharmacological therapy of obesity is limited to
anorexic drugs such as amfepramon and sibutramine and
one malabsorptive drug, orlistat. When added to a diet, such
therapy is expected to yield weight loss of 0.2–0.4kgweek−1,
but only for few weeks due to tolerance and side eﬀects [1].
Eﬀective management of overweight seems to be of
utmost importance especially if modern science can utilize
safe plants derived from traditional medicine to ﬁll the gap
and supplement currently used pharmacological products.
Mild overweight was generally accepted in ancient Arab
societies and considered a reﬂection of a high socioeconomic
level and part of the desired beauty standards in those days.
This fact wasexpressed intheminimal eﬀorttodiscoveranti-
obesity remedies compared with other medical ﬁelds. Only
severe obesity was considered suitable for treatment using
speciﬁc medicinal plants, body exercises and control of food
consumption [2, 3]. Weighlevel is composed of four herbs
developed according to the traditional herbal knowledge of
the Greek-Arab medical system [4–6]. Cuminum cyminum
L.( C u m i n ) ,Mentha longifolia L. (sorting menthe) and Olea
europaea L. (olive) leaf are all classed as foods or spices2 Evidence-Based Complementary and Alternative Medicine
throughout Europe and are taken in large amounts, while
Alchemilla vulgaris L. (lady’s mantle) is regarded as safe by
the German Commission even at large doses without known
adverse eﬀects [7]. Deeply rooted in Arabic medicine, A.
vulgaris L. has been used for treating obesity, gastrointestinal
pain and inﬂammation [8, 9]. Olive leaves are a typical
herbal remedy of the Mediterranean area and reported to
possess hypoglycemic, hypotensive-diuretic and antioxidant
properties [7, 10]. Extracts from both of these plant leaves
have been shown to increase the basal metabolic rate [11,
12]. For centuries, mint as well as cumin has been used
to reduce appetite [8] to improve digestion by relieving
digestive symptoms such as pain, spasm, gas and dyspepsia
and creating a sensation of fullness [13]. The group of
carminative seeds such as cumin, caraway, fennel, dill and
anise have all been acknowledged to have stomach-calming
eﬀects to improve digestion and regulate appetite, especially
in children [14].
All four plants are thus used in European herbalism and
eachwithadiﬀerentindicationforuse.Wehypothesized that
these four plants when combined may generate a synergistic
eﬀect. The present study aimed to investigate the safety and
therapeutic eﬃcacy of a ﬁxed mixture of these four plants.
As for safety, we performed in vitro and animal studies. As
for therapeutic eﬃcacy, we deﬁned it as an incremental and
persistent weight loss during the study period of 4 weeks in
the controlled animal study and of 3 months in the open
human study.
2.Materialsand Methods
The leaves of lady’s mantle, olive and wild mint, as well as
the seeds of cumin were collected from the Galilee region,
dried under shade and powdered to a ﬁne grade as extracts
by Antaki Ltd Laboratories, Kfar Kana, Israel. Weighlevel
tablets (310mgtablet−1) were prepared at Karmat Micro
Encapsulation laboratories, Kibbutz Ramot Menashe, Israel.
Eachtablet contained60mg A.vulgaris L.,50mgO. europaea
L., 20mg Mentha longiforia L., 25mg C. cyminum L., 7mg
vitamin C and 148mg tricalcium phosphate.
2.1. Safety and Oxidative Stress Analysis. Rats and rat liver
homogenates were used to assess safety and antioxidant
eﬀects of Weighlevel.
2.1.1. LD50. Thirty-six male Sprague-Dawley rats (average
weight: 153 ± 12g) were divided into four groups. Large
single doses of Weighlevel were placed directly into the
stomachofeachgroupandobservedfor14daystodetermine
the LD50. Animal study approval was given from the Faculty
of medical school, Technion, Haifa, in 1999.
2.1.2. Oxidative Stress. Oxidative stress leads to generation
of reactive oxygen species (ROS), which play an important
pathogenetic role in diﬀerent disease states. Lipid peroxi-
dation has damaging eﬀects on liver cell membrane. The
extent of lipid peroxidation was measured using a technique
based on the thiobarbituric acid reactive substance (TBARS)
assay that detects malondialdehyde (MDA), an end product
of peroxidative decomposition of polyeonic fatty acids in
in vitro systems [15]. To accurately quantify TBARS in the
analytical procedure, the protein was precipitated before
the addition of thiobarbituric acid to the reaction, while
the antioxidant butylated hydroxytoluene was added before
heating of samples. Rat liver homogenates were incubated
with 100μMF e S O 4 as ROS generating system [16, 17]a n d
with various concentrations of the product.
2.1.3. Lactate Dehydrogenase Assay. Release of the intracellu-
lar enzyme lactate dehydrogenase (LDH) is the consequence
of necrotic or toxic cell membrane rupture. Integrity of the
cell membrane was determined by measuring LDH activity
released into the culture medium [18, 19]. LDH activity was
monitored following the oxidation of NADH as the decrease
in absorbance at 334nm. The reaction was carried out in
a potassium phosphate buﬀer (40mM K2HPO4,1 0 m M
KH2PO4, pH 7.5) containing 0.24mM NADH and 0.62mM
pyruvate. The percentage of LDH released was deﬁned as
the ratio of LDH activity in the supernatant to the sum of
LDH amount released plus LDH activity measured in the
cell lysate. Human ﬁbroblasts were incubated with diﬀerent
amounts of the product extracts, and LDH activity was
measured in the medium at 24, 48 and 72h of incubation.
2.1.4. Thermogenesis. Male Sprague-Dawley rats (n = 12)
were housed in a light and temperature controlled room
(12:12h light:dark cycle and 23◦C) and were given free
access to water and a standard laboratory diet for one-
week adaptation period, before starting the study. Strips
of interscapular brown adipose tissue (IBAT) were rapidly
dissected out from the middle part of the fat pad. The tissues
were perfused with Krebs-Ringer bicarbonate buﬀer of the
following composition: 116.8mM NaCl, 25mM NaHCO3,
5.9mM KCl, 1.2mMMgSO4,1 . 2 m MN a H 2PO4,1 . 2 5 m M
CaCl2 and 5mM glucose. The Weighlevel extract was added
intheperfusionbuﬀermedium,andtheresultingsuspension
was automatically ﬁltered before entering the respiratory
chambers. The medium was bubbled continuously with a
mixture of 95% O2 and 5% CO2 [20, 21]. The respiratory
rates of IBAT fragments were measured by a method involv-
ing repeated O2 uptake determinations, as described by
Bardeetal.[22].TheO2 partial pressure (PO2)wasmeasured
by a Clark O2 electrode when extract administration resulted
in changes in MO2 [23–25].
2.1.5. Eﬃcacy in Chickens. Chickens (average weight around
100g each) were used in the ﬁrst phase of our study because
theyrepresent asimple and aquicktestsystem. Chickenwere
cared for in standard conditions and fed for 1 month with
normal chick food (n = 20), with normal food enriched with
10% Nigella sativa (n = 20) and with normal food enriched
with 3% of the product powder (n = 20). Body weight was
carefully estimated each week.
2.1.6. Clinical Investigations. Human volunteers were select-
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ﬁve diﬀerent clinics in Galilee where they were asked if they
were willing to take a herbal therapy for weight loss after a
thorough explanation of Weighlevel components. The mean
age of 80 subjects recruited into the study was 34.3 ± 9.68
(range 19–53)years. They had an averageweight of90 ± 5kg
and a height of 169 ± 5cm corresponding to a body mass
index(BMI)of30.67 ±2.14kgm−2.Womencomprised48%
of subjects with an age range of 49–67 years. Almost half of
a l ls u b j e c t sw e r eo ns o m em e d i c ations mainly for ischemic
heart disease, diabetes mellitus and/or hypertension. All
medicationswere keptunchanged during the study period as
patients were in a stable clinical condition. Fourteen subjects
were excluded as they violated the protocol, eight due to
lack of compliance and six due to absence from scheduled
visits. Therefore, eﬃcacy and tolerability are given for the
remaining 66 subjects. Human volunteers were asked to
continuetheirdailyactivitiesandhabits,especiallytheirfood
intake,buttorestrict ittothree main mealsand toremember
to take one tablet of Weighlevel 30min before each meal.
Control group was asked to restrict it to three main meals.
All usual medications were kept unchanged during the study
period of3 months. An informed consentwas obtained from
each subject who was given a free-of-charge box containing
90 tablets of Weighlevel. At baseline, the BMI was estimated
foreverysubject.The nextvisitwasscheduledforthecoming
4 weeks and they were asked to return the Weighlevel box so
thatreturnedtabletscouldbecountedasameasureofpatient
compliance with the protocol. This was repeated in each of
the three consequent visits when body weight was estimated
and careful investigations of well-being and of any adverse
eﬀect were undertaken.
2.2. Statistics. The Wilcoxon signed-rank test was used.
Comparisons between groups were performed by the
Wilcoxon rank-sum test. A 0.05 level of signiﬁcance was set.
Data obtained were expressed as mean ± SEM.
3.Results
3.1. Safety Analysis. An extremely high dose of Weighlevel
(15.3gkg−1) was necessary to obtain an LD50 in rats. On
a body weight basis, this would correspond to the human
consumption of more than a kilogram. Similar results were
seen in in vitro studies by measuring the LDH release.
Figure 1 shows the results at 24, 48 and 72h of incubation.
Comparedwith untreatedcontrolcells,nosigniﬁcant change
in LDH release was found, whether as a function of increas-
ing product concentration or as a function of increasing
incubation period.
3.2.Anti-Oxidant. Lipidperoxidationinducedbyincubating
the rat liver homogenate with ferrosulfate is expressed in
Figure 2 as the extent of MDA production. The addition of
a very low dose of the product (10μgml −1) to the medium
signiﬁcantly reducesMDA release from 0.89 ± 0.05to 0.53 ±
0.03nMmg−1 protein (P < .001). Higher concentrations of
the product (50μgml −1) further reduce MDA concentration
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Figure 1: LDH release from cultured human ﬁbroblasts. LDH
release wasassessed24,48,and72hin control cells andWeighlevel-
treated cells (180 and 360mgml−1). Values given represent the
mean ± SEM of three independent experiments carried out in
triplicates.
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Figure 2: Eﬀects of Weighlevel extract diﬀerent on MDA release
from rat liver homogenates incubated with 100μMf e r r o s u l f a t e
in the presence and absence of 0.01, 0.05 and 0.1mg Weighlevel
ml−1. Values given represent the mean ± SEM of three independent
experiments carried out in triplicates.
to 0.28 ± 0.03nMmg−1 protein (P < .001). No further anti-
oxidative eﬀect of the product is noted by increasing its
concentration from 50 to 100μgml −1 (Figure 2).
3.3. Anti-Overweight. Figure 3 summarizes the controlled
eﬃcacy of studies in chickens. Baseline body weight of the
60 chickens was 142 ± 12g and increased to 1000 ± 15g
at 4 weeks in normal chick feeding. In the positive control
group fed with 10% N. sativa and normal food, body weight
was not substantially higher than that of the control group4 Evidence-Based Complementary and Alternative Medicine
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Figure3:Eﬃcacyoffeeding 20chickenswithnormalfoodenriched
with 3% of Weighlevel plant extracts (lower diagram) compared
with normal food (middle diagram, control group) and normal
food enriched with 10% N. sativa (upper diagram, positive control
group). Body weight values at 1, 2, 3 and 4 weeks are not
signiﬁcantly diﬀerent in the controls and positive controls, while
the studied group had signiﬁcantly lower values (P < .005) at 2, 3
and 4 weeks.
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Figure 4: Thermogenesis eﬀects of Weighlevel were determined in
strips of rat IBAT. Values given represent the mean ± SEM of three
independent experiments carried out in triplicates.
during the 4 weeks of the study. Signiﬁcant and incremental
reduced weight gain was seen in the study group fed with
normal food enriched with 3% of product extract week by
week. Body weight in the study group reached 815 ± 10g at
Week 4 (P < .005 versus control and versus positive control
groups). This reduced weight gain in the study group did
not reﬂect a toxic eﬀect since all three groups were healthy
chickens that apparently did not suﬀer from obesity.
3.4. Thermogenesis. The eﬀects of Weighlevel on thermo-
geneis are shown in Figure 4. Weighlevel extracts stimulate
IBATrespiration rate, in adose-dependentmanner upto>3-
fold higher than basal MO2 values.
3.5. Clinical Investigations. The mean age of 80 subjects
recruited into the study was 34.3 ± 9.68 (range 19–53) years.
They had an average weight of 90 ± 5kg and a height of 169
±5cmcorrespondingtoaBMIof31.3±1.1kgm−2.W omen
comprised 48% of subjects, with an age range of 49–67
years. Almost half of all subjects were on some medications
mainly for ischemic heart disease, diabetes mellitus and/or
hypertension. All medications were kept unchanged during
the study period as patients were in a stable clinical
condition. Fourteen subjects were excluded as they violated
the protocol, eight due to lack of compliance and six due
to absence from scheduled visits. Therefore, eﬃcacy and
tolerability are given for the remaining 66 subjects.
Weighlevel was well tolerated in all 66 subjects and no
minor or major adverse eﬀect was noted by any of them.
The product was well tolerated with other medications for
diabetes mellitus, hypertension, cholesterol and ischemic
heart disease. Figure 5 summarizes the eﬃcacy of Weighlevel
in these 66 subjects. Signiﬁcant and progressive weight
reductions were observed each month averaging 1kgweek−1
over3 months. The weight was reducedfrombaseline of90.5
± 1.2 to 78.5 ± 1.4kg at 3 months (P < .0005). A progressive
and signiﬁcant weight loss was seen in these subjects during
the whole study period. Higher levels of weight loss were
seen in people with BMI of 25–30kgm−2 (overweight)
(Figure 5(a)) compared with people with BMI >30kgm−2
(obese) (Figure 5(b)) .T h eB M Iw a sr e d u c e da f t e r3m o n t h s
from 28.5 ± 1.2 and 32.1 ± 1.8kgm−2 to 24.5 ± 1.4 and 27.5
±2.2kgm−2 inoverweight andobesegroup,respectively. No
signiﬁcant eﬀects were seen in the control group who was
a s k e dt or e s t r i c ti tt ot h r e em a i nm e a l s( Figure 5(c)).
4.Discussion
The currently practiced traditional Arabic-Islamic herbal
medicine is greatly underexploited though it may provide
eﬀective new concepts and a rich source of active herbal
compounds.Accordingtoourknowledge,therearecurrently
no Arab traditional medicine training programs in any Arab
country, and Arab medicine has not emerged as a compre-
hensive health alternative comparable to other non-Western
health models. According to recent surveys, more than 2600
plant species are found in the Mediterranean region and
∼200–250 plants are noted for their uses as medicinal herbs
[26–28]. Newly conducted ethnopharmacological survey by
our group revealed that more than 450 plant species are
still used in our region (Said O., Khalil K. and Saad B.,
unpublished data). In the present study, we prepared a
combination of four herbal remedies that are traditionally
known for their weight reduction eﬀects. This combination
is called Weighlevel.
TherecommendedoﬃcialdoseofA.vulgarisL.,themain
medicinal plant in Weighlevel, is 5–10g day−1 of the dried
plant [7]. We showed a high level of safety of Weighlevel.
Toxicity, as deﬁned by the LD50 in rats, was observed only
at the high concentrations of ∼5gkg −1. Concentrations
as high as 360mgml−1 did not show any sign of cellular
toxicity in the LDH test. Yet, the antioxidant properties were
evidenced at concentrations as low as 0.01mgml−1 and were
more signiﬁcant at concentrations of 0.05mgml−1.H i g h e r
concentrations did not substantially add to such properties.
These observations that show a very high therapeutic index
(the diﬀerence between eﬀective and toxic doses) may
explain the lack of any adverse eﬀect in the studied patients.Evidence-Based Complementary and Alternative Medicine 5
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Figure5:ClinicaleﬃcacystudiesofWeighlevelin66humanvolun-
teers who were selected on the basis of routine visits to their general
physicians in ﬁve diﬀerent clinics in Galilee where they were asked
if they were willing to take an herbal therapy for weight loss. The
people were divided into three groups. The ﬁrst group with BMI of
25–30kgm−2 (a), the second group with BMI >30kgm−2 (b) and
the control group (c). Values given represent the mean ± SEM.
The clinical results disclose that Weighlevel is safe and
welltoleratedbyall66subjectsandistherapeuticallyeﬃcient
as weight loss in each subject was incremental and steady
throughout the study period of 3 months.
As experienced in clinical practice, smaller doses of
synergistic drugs may yield a better therapeutic eﬃcacy with
fewer side eﬀe c t s .C u r r e n t l y ,a v a i l a b le pharmaceutical drugs
when added to a diet are expected to result in weight loss of
0.2–0.4kgweek−1 [1]. In the present study, all subjects were
askedtocontinuetheirusualhabitsoffoodintake,buttotake
only three main meals daily, without snacks in between. We
observed weight loss of ∼1kgweek−1 during each of the 12
study weeks, thus reducing the average individual weight by
∼12kg during 3 months. The exclusion of 14 subjects was
due to the lack of compliance and not due to the lack of
eﬃcacy.
As evidenced in the controlled studies in chickens, the
reduced weight gain was substantial during 4 weeks in the
study group. This could have reﬂected a toxic eﬀect of
Weighlevel in these chickens. All three chicken groups that
were fed with the same quality and quantity of normal chick
food, were apparently healthy before and during the four
study weeks, and each chicken in the three groups normally
increased its weight. However, the weight gain in the positive
control group was not substantially above that in the control
group, whereas it was signiﬁcantly less in the study group.
Therefore, it seems more likely that the observed eﬀects of
Weighlevel in these chickens are due to an increased and
extended time of satiety and the sensation of fullness along
with an augmented basal metabolic rate.
We speculate that the combination of the four plants in
Weighlevel acts to increase both satiety and thermogenesis
in brown adipocytes by measuring thermogenesis in male
Sprague-Dawley rats. This system is generally accepted as
a model for fat depletion (fat burning). The amines of A.
vulgaris L. are mainly the tannins reported to increase the
metabolic rate in cold environments [11] and the ﬂavonoids
are reported to regulate digestive enzymes and to have
cardioprotective eﬀects [29]. Besides metabolic stimulation
[12], olive leaf extracts were shown to inhibit intestinal
glucose absorption, and a hypoglycemic eﬀect was reported
together with hypotensive and hypolipidemic properties
[30–32]. Olive leaves are thus known to reduce fat load
and circulatory fat levels. Wild mint was reported to relax
the stomach and increase gastric emptying and the passage
of food through the digestive system [33]. Cumin was also
reported to improve glucose utilization, reduce raised blood
sugar and promote digestion by stimulating gastrointestinal
mucosa and pancreatic digestive enzymes [34, 35].
In addition to the anti-overweight eﬀects of our plant
combination, a positive and desired antioxidant activity was
observed. This ﬁnding is of great importance for people
suﬀering from obesity who usually have high levels of
oxidative stress. Based on these ﬁndings and taking into
consideration the possibility of a tailing oﬀ of eﬀectiveness
with time, we would encourage further research worldwide,
in particular a multi-center open trial in extremely obese
subjects. A weight loss of ∼0–50kg is to be expected during
1 year of Weighlevel administration three times daily and
30min before each main meal.
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